-
Louis's Most Recent
Articles
Hey, NIO Stock Investors! Don’t Forget This Warning.
The automaker spun its adjusted fourth-quarter 2022 delivery forecast as 'prudent,' but NIO stock traders should detect a big red flag.
Should You Buy the Big Banks Before Earnings on Friday?
The “official” start of the fourth-quarter earnings season is now just a few short days away, with the big banks set to kick off the earnings season before the market opens this Friday.
Calm Waters Are NOT a Sign to Buy SOFI Stock
As upside potential stays murky, and with little sign of the story changing, there's still little reason to make SOFI stock a buy.
Buy NVDA? Nope. Stay on the Sidewalk as Nvidia Zooms Into Automotive Tech.
NVDA stock has the potential to move into "buy" territory someday. For the time being, though, Nvidia's financials have too many red flags.
Weekly Upgrades and Downgrades
During these busy times, it pays to stay on top of the latest profit opportunities. And today's blog post should be a great place to start. After taking a close look at the latest data on institutional buying pressure and each company's fundamental health, I decided to revise my Portfolio Grader recommendations for 98 big blue chips. Chances are that you have at least one of these stocks in your portfolio, so you may want to give this list a skim and act accordingly.
Is QuantumScape Stock a Sell? You Bet.
It's fine to be long-term bullish on EV batteries, but there's too much risk involved to hold QS stock with confidence now.
Quant Ratings Updated on 59 Stocks
I decided to revise my Portfolio Grader recommendations for 59 blue chip stocks. Chances are you have at least one of these stocks in your portfolio, so you may want to give this list a skim accordingly.
Is 2023 the Year for Tech?
2022 was a tough year for tech stocks, with the tech-heavy NASDAQ ending the year down a whopping 33.1%. Unfortunately, 2023 doesn’t look much better, as the NASDAQ continues to lag the S&P 500 and Dow.
This Move Could Be Disastrous for Lucid Stock
LCID stock was a poor performer last year, and 2023 could be even worse for Lucid as the company makes a risky move into a crowded market.
Earnings Will Drive Stocks Higher
It’s easy to be negative after a rough 12 months for the stock market. But as always, I encourage you to tune out the fear-mongering media and stay positive. Earnings season kicks off in earnest next week, with the big banks first to report. And we already are seeing evidence that earnings are working…
Don’t Bank on a Late 2023 Recovery for SOFI Stock
Until the story with SOFI stock really changes, continue to steer clear.
Delisting Threat Casts Doubt on CENN Stock
CENN stock traders should be on high alert as Cenntro Electric's expenditures grow and the company sells relatively few vehicles.
Mullen Stock Belongs in the Stock Market Junkyard
The takeaway here with MULN stock is pretty simple. Avoid this former "meme favorite" at all costs.
Reverse Share Split Won’t Save Camber Energy Stock
CEI stock may be higher-priced now, but it's actually still on a downward path as Camber Energy's short-term fix isn't a real solution.
My Three Predictions for 2023
Welcome to 2023! I hope you had a wonderful New Year and enjoyed the long holiday. I want to use today’s Market 360 to share my three top predictions for 2023. Let’s dive in.
Weekly Upgrades and Downgrades
During these busy times, it pays to stay on top of the latest profit opportunities. And today's blog post should be a great place to start. After taking a close look at the latest data on institutional buying pressure and each company's fundamental health, I decided to revise my Portfolio Grader recommendations for 59 big blue chips. Chances are that you have at least one of these stocks in your portfolio, so you may want to give this list a skim and act accordingly.
The One Path GOOG Stock Could Take to Pay Off for Investors
However, don't take this to mean it's time to jump into GOOG stock today. There's little reason to buy merely on the hopes of the aforementioned changes happening. Wait for more signs to emerge that the company will pursue this potentially more fruitful path.
Why LLY Stock Could Meet (or Beat!) 2022’s Stellar Performance
From dividend increases to multiple anticipated drug launches, Eli Lilly continues to give prospective investors reasons to buy LLY stock.
Why the NIO Stock Pullback Will Continue
Don't expect a bottoming-out, much less a rebound, to play out for NIO stock anytime soon.
